<DOC>
	<DOCNO>NCT02438540</DOCNO>
	<brief_summary>The investigator design randomize double blind ( patients/ assessor ) clinical trial compare therapeutic effect Metformin monotherapy Metformin acupuncture combine therapy weight loss insulin sensitivity among overweight/obese type 2 diabetes mellitus ( T2DM ) patient . We compare inflammatory marker , lipid profile , adipokines overweight/obese T2DM patient receive combined therapy receive Metformin monotherapy , understand whether acupuncture plus Metformin good approach Metformin treat diabetes .</brief_summary>
	<brief_title>Comparative Effect Metformin Acupuncture Weight Loss Insulin Sensitivity</brief_title>
	<detailed_description>From 39 participant , 19 participant send case group 20 control group accord mention method randomization independent research assistant . In case group enrol participant treat Metformin monotherapy receive electro acupuncture ( EA ) Auricular acupuncture select acupoints , participant control group treat Metformin monotherapy receive sham EA . All patient blind treatment assignment period study assessor blind name patient result well . IR calculate homeostasis model assessment insulin resistance ( HOMA-IR ) propose Matthews et al . HOMA-IR = ( fast insulin ( mmol/L ) × fast glucose ( µIU/ml ) ) /22.5 ; body height measure accuracy +/-0.1cm ; body weight measured subject dress light clothing overnight fast standard scale accuracy +/-0.1 kg ; The body mass index ( BMI ) calculate divide weight ( kg ) height ( square m² ) . Blood marker include fast blood sugar ( FBS ) , fast insulin ( FINS ) , interleukin-6 ( IL-6 ) , tumor necrosis α ( TNFα ) , C reactive protein ( CRP ) , leptin , adiponectin , resistin , glucagon-like peptide-1 ( GLP-1 ) , HOMA index , free fatty acid ( FFAs ) , low density lipoprotein cholesterol ( LDLc ) , high density lipoprotein cholesterol ( HDLc ) , ceramides ; calculate measure draw 10 ml blood cubital vein patient 8 hour overnight fasting , treatment , FBS , FINS HOMA index 30 min treatment additionally , 3 time study ( begin , 5th time end ) group , choose research standard range . All data standard range manage Epi-data software , analyze Statistical Package Social Sciences ( SPSS ) software 15.0.0 ( 6 Sep 2006 ) . The investigator statistic method include T-test repeat measure ANOVA . P-Value &lt; 0.05 statistically significant trial</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Who diagnose type 2 diabetes mellitus use Metformin monotherapy well control diabetes period study previously ( 500 mg one/two/three time per day ) All patient overweight accord BMI ≥25 Individuals nephritic syndrome ( urine protein 3.5 g/day ) , edema renal failure ( serum creatinine 115 µmol/L ) Individuals diagnose heart failure ( NYHA Fc IIIIV ) pacemaker implant Individuals abnormal liver dysfunction ( GOT glutamatepyruvate transaminase ( GPT ) level twofold normal range ) diagnosis liver cirrhosis Individuals high HbA1C level ( HbA1C 9 % ) Pregnant woman Individuals receive insulin therapy already Individuals receive therapy change dosage period therapy Individuals suffer endocrine abnormality Thyroid disease , polycystic ovary syndrome ( PCOS ) , etc Individuals receive weight loss medicine , anti depressant agent ' hormonal medicine last 3 month period study Individuals suffer homeostasis disorder systemic disease Individuals comply ( sign inform consent ) treatment study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>acupuncture</keyword>
	<keyword>obesity</keyword>
	<keyword>type 2 diabetic mellitus</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>metformin</keyword>
	<keyword>inflammatory factor</keyword>
	<keyword>adipokines</keyword>
	<keyword>lipid profile</keyword>
</DOC>